Effect of Etoposide on Human Bone Marrow Cells
Author Information
Author(s): R. Bailey-Wood, C.M. Dallimore, T.J. Littlewood, D.P. Bentley
Primary Institution: Department of Haematology, University Hospital of Wales
Hypothesis
How does etoposide affect the growth of human CFU-GM bone marrow progenitor cells?
Conclusion
Etoposide significantly affects the growth of CFU-GM cells, with protein binding altering its cytotoxic effects.
Supporting Evidence
- Etoposide shows a simple log-linear relationship with CFU-GM growth.
- The D50 concentration for CFU-GM without albumin is 0.0098 μg/ml.
- Adding BSA increases the D50 concentration to 0.042 μg/ml.
- HSA shows a greater effect than BSA, with a D50 of 0.375 μg/ml.
Takeaway
Etoposide is a drug that can help treat cancer, but it can also harm bone marrow cells, which are important for making blood.
Methodology
Bone marrow was obtained from patients, and CFU-GM growth was measured after incubation with etoposide for 7 days.
Limitations
The study only examines CFU-GM and does not measure true stem cell response.
Participant Demographics
Patients undergoing thoracotomy who were haematologically normal.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website